By Kamal Choudhury and Sneha S K Feb 26 (Reuters) - The U.S. Food and Drug Administration plans to give quarterly bonuses to ...
The US Food and Drug Administration plans to give bonuses to scientific staff for speeding up drug reviews, according to an ...
The plan raises a number of questions, including how the payments will be distributed across large teams of staffers.
The FDA already authorizes the use of experimental drugs under what’s called “compassionate use,” for people with no other ...
BALTIMORE — Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy labs, sickened some 8,000 or more Marylanders a year by 2024. The Food and ...
New FDA guidelines for personalized genomic drug development are a step forward in advancing new therapies for ultrarare diseases, but industry leaders need further clarification.
WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...
Investor's Business Daily on MSN
UniQure plummets as FDA's Marty Makary disparages rejected rare disease drug
Uniqure stock plummeted Thursday after Marty Makary appeared on CNBC to defend the FDA's recent rejections of rare disease drugs.
A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results